Frontlight ResearchEarly access
Trial site
Nottingham
- 4running trials
- 7closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Multiple sclerosis2 trials
- IgA nephropathy1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Triple-negative breast cancer1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Terminated
Terminated
Completed
Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026